If Im honest, much of my life has been constructed around managing my weight
In AD mouse models, pathophysiological changes, such as anti-apoptotic effects, reduced A deposition and phosphorylated hippocampal tau, protection from synapse loss, reduced inflammatory and oxidative stress response in the cortex and hippocampus, and increased BDNF have been observed [119,120,121]
Together, these findings highlight the early but promising role of GLP-1 therapies in addressing both obesity and maladaptive reward-driven behaviors, as the clinical landscape continues to evolve
Introduction Alzheimers disease (AD), a global public health priority, is the most common neurodegenerative disease ( Some human and animal studies show that insulin can accelerate the clearance level of A in the brain and affects the phosphorylation of tau protein, meanwhile, enhances the synaptic activity and plasticity of neurons ( Glucagon-like peptides 1 (GLP-1), derived from intestinal L cells, is an incretin hormone
The high behavioral-support rate in STEP-3 did not reduce GI event frequency, confirming that GI effects are pharmacological rather than behavioral
Munroe, D